AmacaThera
Latest round
- Series A
Last raised
- Nov 2023
Total raised
- $41M
Investors
- 11
About AmacaThera
Based in Toronto, Canada, AmacaThera Inc.AmacaThera Inc. focuses on innovative drug delivery systems, specifically through its flagship AmacaGel platform.AmacaThera Inc. specializes in advanced sustained release hydrogel formulations, with its core product being the AmacaGel delivery platform. This injectable hydrogel technology enables localized and sustained drug delivery to enhance patient outcomes, particularly in post-surgical pain management and cancer treatment. The flagship product, AMT-143, is designed for non-opioid acute pain management and has recently undergone clinical trials.AmacaThera’s revenue model is built on partnerships with healthcare providers and institutions that utilize its therapeutic products. Their operations typically involve agreements with hospitals and clinics to integrate the AmacaGel platform into pain management protocols.In November 2023, AmacaThera Inc. The company aims to launch new products to enhance their therapeutic offerings and plans to explore market expansion into new geographic regions.
Who invested in AmacaThera
11 investors across 4 rounds
See all investors in AmacaThera
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about AmacaThera
Who invested in AmacaThera?
AmacaThera has 11 investors on record across 4 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has AmacaThera raised?
AmacaThera has raised 4 venture rounds. Sign up free to see how much each round raised and the total.
When did AmacaThera last raise money?
AmacaThera's most recent round on record is a Series A, in Nov 2023.
What does AmacaThera do?
Based in Toronto, Canada, AmacaThera Inc.
Where is AmacaThera headquartered?
AmacaThera is headquartered in Toronto, Canada.
Which VCs invest in companies like AmacaThera?
Among active investors with capital left to deploy, S2G Ventures, CAVU Consumer Partners, Gaingels and Alumni Ventures Group back materials companies at AmacaThera's stage. Their profiles are linked below.
VCs backing materials startups at Series A
Raising like AmacaThera? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.